Thyroid Tablets recall
FDA recall D-0866-2026 · initiated Aug 21, 2026
VITRUVIAS THERAPEUTICS INC recalled Thyroid Tablets in Aug 2026 — an FDA Class I recall (D-0866-2026) because Superpotent Drug.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Superpotent Drug
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 1955 bottles
Details
- Product
- Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
- Recalling company
- VITRUVIAS THERAPEUTICS INC
- Classification
- Class I
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- US Nationwide.
- Initiated
- Aug 21, 2026
- FDA report date
- Sep 23, 2026
Frequently asked
- Was Thyroid Tablets recalled?
- VITRUVIAS THERAPEUTICS INC recalled Thyroid Tablets in Aug 2026 — an FDA Class I recall (D-0866-2026) because Superpotent Drug. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was Thyroid Tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0866-2026 was: Superpotent Drug
- Is a recalled Thyroid Tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Thyroid Tablets are affected?
- Distributed: US Nationwide.. The recall covers these lots — Lot # 504950, Exp Date: 09/30/2026.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0866-2026.